American Cannabis Company, Inc. 8-K

What Happened
American Cannabis Company, Inc. (AMMJ) filed an 8-K reporting that on December 23, 2025, Ellis Smith resigned from his roles as Chief Executive Officer, Chief Financial Officer and Chairman of the Board, effective immediately. The board stated the resignation was not due to any disagreement with the company. On the same date the board appointed Joe Cleghorn as Interim Chief Executive Officer and added James Woodend as a director, both effective immediately.

Key Details

• Resignation date: December 23, 2025 — Ellis Smith resigned as CEO, CFO and Chair.
• Interim CEO: Joe Cleghorn appointed effective December 23, 2025.
• Board addition: James Woodend appointed as a director effective December 23, 2025.
• No special arrangements: The filing notes no agreements or understandings led to these selections beyond normal corporate governance; no compensatory arrangements were disclosed in the filing.

Why It Matters
Leadership changes at the CEO and CFO level are material events that can affect strategy, operations and investor confidence. Investors should note the immediate interim appointment and the board addition, and monitor future filings (e.g., any compensation agreements, succession plans, or further director changes) for details on permanent leadership and potential impacts on company direction and financial reporting.